Literature DB >> 9426866

Pathogenesis of Parkinson's disease.

A H Schapira1.   

Abstract

The aetiology and pathogenesis of Parkinson's disease (PD) remain unknown. There is a consensus emerging that there are likely to be multiple aetiologies that may result in the clinical and pathological abnormalities common to the majority of patients with idiopathic PD. Genetic factors have been suggested as important in either the cause of PD or in determining susceptibility. The recent linkage in one large pedigree of a gene for autosomal dominant parkinsonism to chromosome 4q21-23 and the subsequent identification of a mutation in the alpha-synuclein gene of this region are important steps towards identifying a biochemical deficiency capable of causing selective dopaminergic cell death. However, the relevance of such a defect to the majority of patients with apparent sporadic PD remains to be established. Factors that may predispose to substantia nigral cell loss, including mitochondrial dysfunction and oxidative damage, could be common to a number of separate aetiologies. A better understanding of these and their relationship to neuronal loss may provide further clues to aetiology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426866

Source DB:  PubMed          Journal:  Baillieres Clin Neurol        ISSN: 0961-0421


  18 in total

1.  Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity.

Authors:  Sharareh Emadi; Hedieh Barkhordarian; Min S Wang; Philip Schulz; Michael R Sierks
Journal:  J Mol Biol       Date:  2007-03-07       Impact factor: 5.469

2.  Tau haploinsufficiency causes prenatal loss of dopaminergic neurons in the ventral tegmental area and reduction of transcription factor orthodenticle homeobox 2 expression.

Authors:  Meige Zheng; Luyan Jiao; Xiaolu Tang; Xianhong Xiang; Xiaomei Wan; Yan Yan; Xingjian Li; Guofeng Zhang; Yonglin Li; Bin Jiang; Huaibin Cai; Xian Lin
Journal:  FASEB J       Date:  2017-04-19       Impact factor: 5.191

3.  Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.

Authors:  Guoxiang Liu; Jia Yu; Jinhui Ding; Chengsong Xie; Lixin Sun; Iakov Rudenko; Wang Zheng; Namratha Sastry; Jing Luo; Gay Rudow; Juan C Troncoso; Huaibin Cai
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

Review 4.  The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis.

Authors:  Chun-lin Ma; Li Su; Juan-juan Xie; Jian-xiong Long; Peng Wu; Lian Gu
Journal:  J Neural Transm (Vienna)       Date:  2013-09-22       Impact factor: 3.575

5.  Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1.

Authors:  Xian Lin; Loukia Parisiadou; Carmelo Sgobio; Guoxiang Liu; Jia Yu; Lixin Sun; Hoon Shim; Xing-Long Gu; Jing Luo; Cai-Xia Long; Jinhui Ding; Yolanda Mateo; Patricia H Sullivan; Ling-Gang Wu; David S Goldstein; David Lovinger; Huaibin Cai
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

6.  Detecting morphologically distinct oligomeric forms of alpha-synuclein.

Authors:  Sharareh Emadi; Srinath Kasturirangan; Min S Wang; Philip Schulz; Michael R Sierks
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

7.  Rosmarinic acid inhibits 6-OHDA-induced neurotoxicity by anti-oxidation in MES23.5 cells.

Authors:  Pei Ren; Hong Jiang; Ronggui Li; Jun Wang; Ning Song; Hua-Min Xu; Jun-Xia Xie
Journal:  J Mol Neurosci       Date:  2009-02-14       Impact factor: 3.444

8.  MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein.

Authors:  Hyun Jin Cho; Guoxiang Liu; Seok Min Jin; Loukia Parisiadou; Chengsong Xie; Jia Yu; Lixin Sun; Bo Ma; Jinhui Ding; Renée Vancraenenbroeck; Evy Lobbestael; Veerle Baekelandt; Jean-Marc Taymans; Ping He; Juan C Troncoso; Yong Shen; Huaibin Cai
Journal:  Hum Mol Genet       Date:  2012-11-02       Impact factor: 6.150

9.  Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells.

Authors:  Vellareddy Anantharam; Siddharth Kaul; Chunjuan Song; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2007-08-25       Impact factor: 4.294

Review 10.  miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease.

Authors:  Gohar Mushtaq; Nigel H Greig; Firoz Anwar; Mazin A Zamzami; Hani Choudhry; Munvar M Shaik; Ian A Tamargo; Mohammad A Kamal
Journal:  Med Chem       Date:  2016       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.